Here begins the text.

The 3rd Subcommittee on Therapeutic Products Based on Extracellular Vesicles (EVs) Including Exosomes

Press Release

When clicking with the mouse or pressing the tab key, Press Release is displayed.

Monday, January 17, 2022   14:00-16:25
* Given the impact of COVID-19, the conference was held online.

Agenda / List of Handouts

  1. Lecture on Therapeutic Products Based on Extracellular Vesicles (EVs) Including Exosomes and Discussion
    • Current Status and Future Prospects of New Drug Development Based on Exosomes
       (Specially Appointed Professor SAWA Yoshiki of Graduate School of Medicine,
        Osaka University)
  2. Prewriting the Assigned Parts to Members
  3. Others

List of Handouts

Confidentiality Classification of Handouts

Document 1

Lecture Material by Specially Appointed Professor SAWA

Document 2

Summary of Discussions at the 1st Working Group

Document 3

Lecture Material by Professor TAKAKURA (Chairperson of the Subcommittee)

Document 4

Draft Report (Integrated Version)

Reference Document 1

Member List of the Subcommittee on Therapeutic Products Based on Extracellular Vesicles (EVs) Including Exosomes

 

JCN 3010005007409

Shin-Kasumigaseki Building, 3-3-2 Kasumigaseki,
Chiyoda-ku, Tokyo 100-0013 Japan

  • Contact us
  • Access/Map

Copyright (C) Pharmaceuticals and Medical Devices Agency, All Rights Reserved.

000048957
0
The 3rd Subcommittee on Therapeutic Products Based on Extracellular Vesicles (EVs) Including Exosomes
/english/rs-sb-std/sb/subcommittees/0020.html
en